Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;72(7):1059-1063.
doi: 10.1002/art.41285. Epub 2020 May 10.

On the Alert for Cytokine Storm: Immunopathology in COVID-19

Lauren A Henderson  1 , Scott W Canna  2 , Grant S Schulert  3 , Stefano Volpi  4 , Pui Y Lee  1 , Kate F Kernan  2 , Roberto Caricchio  5 , Shawn Mahmud  6 , Melissa M Hazen  1 , Olha Halyabar  1 , Kacie J Hoyt  1 , Joseph Han  7 , Alexei A Grom  3 , Marco Gattorno  4 , Angelo Ravelli  8 , Fabrizio De Benedetti  9 , Edward M Behrens  10 , Randy Q Cron  11 , Peter A Nigrovic  12
Affiliations

On the Alert for Cytokine Storm: Immunopathology in COVID-19

Lauren A Henderson et al. Arthritis Rheumatol. 2020 Jul.

Abstract

Poor outcomes in COVID-19 correlate with clinical and laboratory features of cytokine storm syndrome. Broad screening for cytokine storm and early, targeted antiinflammatory therapy may prevent immunopathology and could help conserve limited health care resources. While studies are ongoing, extrapolating from clinical experience in cytokine storm syndromes may benefit the multidisciplinary teams caring for patients with severe COVID-19.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The family of conditions characterized by cytokine storm. Malig. = malignancy; Assoc. = associations; SJIA = systemic juvenile idiopathic arthritis; MAS = macrophage activation syndrome; CRS = cytokine release syndrome; ARDS = acute respiratory distress syndrome; EBV = Epstein‐Barr virus; HLH = hemophagocytic lymphohistiocytosis.
See this image and copyright information in PMC

Comment in

References

    1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62. - PMC - PubMed
    1. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020. E‐pub ahead of print. - PMC - PubMed
    1. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunologic features in severe and moderate coronavirus disease 2019. J Clin Invest 2020;130:2620–9. - PMC - PubMed
    1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506. - PMC - PubMed
    1. Eloseily EM, Weiser P, Crayne CB, Haines H, Mannion ML, Stoll ML, et al. Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis. Arthritis Rheumatol 2020;72:326–34. - PubMed

Publication types